Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Mary E. Devens"'
Autor:
Paras Shah, William R. Taylor, Brianna J. Negaard, Benjamin R. Gochanour, Douglas W. Mahoney, Sara S. Then, Mary E. Devens, Patrick H. Foote, Karen A. Doering, Kelli N. Burger, Brandon Nikolai, Michael W. Kaiser, Hatim T. Allawi, John C. Cheville, John B. Kisiel, Matthew T. Gettman
Publikováno v:
Life, Vol 14, Iss 8, p 1024 (2024)
Introduction: Non-invasive assays are needed to better discriminate patients with prostate cancer (PCa) to avoid over-treatment of indolent disease. We analyzed 14 methylated DNA markers (MDMs) from urine samples of patients with biopsy-proven PCa re
Externí odkaz:
https://doaj.org/article/6ad792f6a8a5470c9e125e29b0e26bc6
Autor:
Minsuk Kim, Emily Vogtmann, David A. Ahlquist, Mary E. Devens, John B. Kisiel, William R. Taylor, Bryan A. White, Vanessa L. Hale, Jaeyun Sung, Nicholas Chia, Rashmi Sinha, Jun Chen
Publikováno v:
mBio, Vol 11, Iss 1 (2020)
ABSTRACT Colorectal adenomas are precancerous lesions of colorectal cancer (CRC) that offer a means of viewing the events key to early CRC development. A number of studies have investigated the changes and roles of gut microbiota in adenoma and carci
Externí odkaz:
https://doaj.org/article/4c9dce8970ac4103b3c5282d6a0dfa44
Autor:
Karthik V. Giridhar, Fergus J. Couch, Jason P. Sinnwell, Seth W. Slettedahl, William R. Taylor, Douglas W. Mahoney, Patrick H. Foote, Maria C. O’Connell, Mariah J. Robran, Mary E. Devens, Anna M. Gonser, Nicole Larson, Karen A. Doering, Kelli N. Burger, Michael Kaiser, Hatim Allawi, Kathryn Ruddy, Janet Olson, John B. Kisiel
Publikováno v:
Cancer Research. 83:P2-11
Objective: Aberrantly methylated DNA may be used to detect minimal residual disease or early recurrence in breast cancer. As a 1st step, we aimed to develop an MDM panel to delineate between healthy women, stage I-III breast cancer in remission with
Autor:
David A. Ahlquist, Han-Kwang Yang, Thomas C. Smyrk, Graham P. Lidgard, Hatim T. Allawi, Seth W. Slettedahl, Douglas W. Mahoney, John B. Kisiel, Lisa A. Boardman, Mary E. Devens, Patrick H. Foote, Xiaoming Cao, Calise K. Berger, Brian A. Dukek, William R. Taylor, Tracy C. Yab, Hyuk-Joon Lee, Boram Choi, Yun-Suhk Suh, Bradley W. Anderson
Purpose: Gastric adenocarcinoma is the third most common cause of cancer mortality worldwide. Accurate and affordable noninvasive detection methods have potential value for screening and surveillance. Herein, we identify novel methylated DNA markers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10c89e26451f7b4d567d18961fe49fbd
https://doi.org/10.1158/1078-0432.c.6527496
https://doi.org/10.1158/1078-0432.c.6527496
Autor:
David A. Ahlquist, Han-Kwang Yang, Thomas C. Smyrk, Graham P. Lidgard, Hatim T. Allawi, Seth W. Slettedahl, Douglas W. Mahoney, John B. Kisiel, Lisa A. Boardman, Mary E. Devens, Patrick H. Foote, Xiaoming Cao, Calise K. Berger, Brian A. Dukek, William R. Taylor, Tracy C. Yab, Hyuk-Joon Lee, Boram Choi, Yun-Suhk Suh, Bradley W. Anderson
Supplemental Figure 1: Quantitative allele-specific real-time target and signal amplification (QuARTS) assay.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65ca121241bd67377b956241a7835450
https://doi.org/10.1158/1078-0432.22470279
https://doi.org/10.1158/1078-0432.22470279
Autor:
David A. Ahlquist, Han-Kwang Yang, Thomas C. Smyrk, Graham P. Lidgard, Hatim T. Allawi, Seth W. Slettedahl, Douglas W. Mahoney, John B. Kisiel, Lisa A. Boardman, Mary E. Devens, Patrick H. Foote, Xiaoming Cao, Calise K. Berger, Brian A. Dukek, William R. Taylor, Tracy C. Yab, Hyuk-Joon Lee, Boram Choi, Yun-Suhk Suh, Bradley W. Anderson
Supplemental Table 1: Discrimination for gastric adenocarcinoma (GAC) from normal gastric mucosa by the top 22 methylated DNA marker candidates in Discovery and Technical Validation Sets. Supplemental Table 2: Function of Genes Containing Differentia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b136c8ec5309b04eb576c79485dfe20
https://doi.org/10.1158/1078-0432.22470276
https://doi.org/10.1158/1078-0432.22470276
Autor:
Jordan K. Voss, Derek W. Ebner, Keli N. Burger, Douglas W. Mahoney, Mary E. Devens, Kari L. Lowrie, John B. Kisiel
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
Multitarget stool DNA (mt-sDNA) testing is a stool-based screening test for colorectal cancer (CRC). In a single instance of testing, the pivotal FDA-approval study (NCT01397747) found that 16% of mt-sDNA tests were positive, and the positive predict
Autor:
David O. Prichard, Eduardo A. Rodriguez, Sara Then, Kelli N. Burger, Douglas W. Mahoney, Kari L. Lowrie, Allon Kahn, Lila J. Finney, Jamie Bering, Jason D. Eckmann, David A. Ahlquist, John B. Kisiel, Karen A. Doering, Derek Ebner, Mary E. Devens, Paul J. Limburg, Barry M. Berger, Michael B. Wallace, Suryakanth R. Gurudu
Publikováno v:
The American Journal of Gastroenterology
OBJECTIVES: Multitarget stool DNA (MT-sDNA) testing has grown as a noninvasive screening modality for colorectal cancer (CRC), but real-world clinical data are limited in the post-FDA approval setting. The effect of previous colonoscopy on MT-sDNA pe
Autor:
Paras Shah, William R. Taylor, Brianna J. Gysbers, Douglas W. Mahoney, Sara S. Then, Mary E. Devens, Patrick H. Foote, Karen A. Doering, Kelli Burger, Brandon Nikolai, Michael W. Kaiser, Hatim T. Allawi, John B. Kisiel, Matthew Gettman
Publikováno v:
Journal of Clinical Oncology. 40:5091-5091
5091 Background: Controversy surrounding prostate-specific antigen (PSA) based screening for prostate cancer (PCa) highlights the need for non-invasive assays that better discriminate patients with and without clinically significant prostate cancer (
Autor:
Thomas E. Witzig, William R. Taylor, Douglas W. Mahoney, William R. Bamlet, Patrick H. Foote, Kelli Burger, Karen A. Doering, Mary E. Devens, Jacquelyn R. Arndt, Maria O'Connell, Calise K. Berger, Anne Novak, James Robert Cerhan, Jacquelyn Hennek, Viatcheslav E. Katerov, Hatim T. Allawi, Dragan Jevremovic, Linda N Dao, Rondell P. Graham, John B. Kisiel
Publikováno v:
Journal of Clinical Oncology. 40:7562-7562
7562 Background: Lymphoma is the 6th most common cancer and a top 10 cause of cancer deaths. To date, there are no blood test approaches to population screening, and accurate surveillance markers are limited. Methylated DNA markers (MDMs) are broadly